EyePoint Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EYPT and other ETFs, options, and stocks.

About EYPT

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. 

CEO
Nancy Sue Lurker
CEONancy Sue Lurker
Employees
123
Employees123
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
1987
Founded1987
Employees
123
Employees123

EYPT Key Statistics

Market cap
261.33M
Market cap261.33M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
159.89K
Average volume159.89K
High today
$7.76
High today$7.76
Low today
$7.03
Low today$7.03
Open price
$7.03
Open price$7.03
Volume
181.74K
Volume181.74K
52 Week high
$21.50
52 Week high$21.50
52 Week low
$6.91
52 Week low$6.91

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

EYPT Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 2, Pre-Market
ActualExpected Nov 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.